387 related articles for article (PubMed ID: 12771939)
21. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
23. PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site.
López-Rodríguez C; Corbí AL
Eur J Immunol; 1997 Aug; 27(8):1843-7. PubMed ID: 9295016
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the promoter region of the human IGHMBP2 (Smubp-2) gene and its response to TPA in HL-60 cells.
Uchiumi F; Enokida K; Shiraishi T; Masumi A; Tanuma S
Gene; 2010 Sep; 463(1-2):8-17. PubMed ID: 20441787
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
26. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
27. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C.
DeKoter RP; Geadah M; Khoosal S; Xu LS; Thillainadesan G; Torchia J; Chin SS; Garrett-Sinha LA
J Immunol; 2010 Dec; 185(12):7374-84. PubMed ID: 21057087
[TBL] [Abstract][Full Text] [Related]
28. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
Flajolet M; Gegonne A; Ghysdael J; Tiollais P; Buendia MA; Fourel G
Oncogene; 1997 Aug; 15(9):1103-10. PubMed ID: 9285565
[TBL] [Abstract][Full Text] [Related]
29. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.
Kistler B; Pfisterer P; Wirth T
Oncogene; 1995 Sep; 11(6):1095-106. PubMed ID: 7566969
[TBL] [Abstract][Full Text] [Related]
31. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.
Zhao X; Jimenez C; Sentsui H; Buehring GC
Virus Res; 2007 Mar; 124(1-2):113-24. PubMed ID: 17123656
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line.
Solomon LA; Li SK; Piskorz J; Xu LS; DeKoter RP
BMC Genomics; 2015 Feb; 16(1):76. PubMed ID: 25765478
[TBL] [Abstract][Full Text] [Related]
33. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression.
Kim YM; Kang HS; Paik SG; Pyun KH; Anderson KL; Torbett BE; Choi I
J Immunol; 1999 Aug; 163(4):2000-7. PubMed ID: 10438937
[TBL] [Abstract][Full Text] [Related]
34. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
35. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
36. Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
Luo H; Tian M
Mol Immunol; 2010 Apr; 47(7-8):1383-95. PubMed ID: 20299102
[TBL] [Abstract][Full Text] [Related]
37. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
[TBL] [Abstract][Full Text] [Related]
38. Hormone regulation of bovine leukemia virus via the long terminal repeat.
Niermann GL; Buehring GC
Virology; 1997 Dec; 239(2):249-58. PubMed ID: 9434716
[TBL] [Abstract][Full Text] [Related]
39. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
[TBL] [Abstract][Full Text] [Related]
40. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
Mouri F; Tsukada J; Mizobe T; Higashi T; Yoshida Y; Minami Y; Izumi H; Kominato Y; Kohno K; Tanaka Y
Eur J Haematol; 2008 Jan; 80(1):10-9. PubMed ID: 18173740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
